
Frequency of serological non-responders and false-negative RT-PCR leads to SARS-CoV-2 testing: a population-based research
Aims The sensitivity of molecular and serological strategies for COVID-19 testing in an epidemiological setting is just not effectively described. The intention of the research was to find out the frequency of damaging RT-PCR outcomes at first scientific presentation in addition to damaging serological outcomes after a follow-up of at the least Three weeks. Strategies Amongst all sufferers seen for suspected COVID-19 in Liechtenstein (n=1921), we included initially RT-PCR constructive index sufferers (n=85) in addition to initially RT-PCR damaging (n=66) for follow-up with SARS-CoV-2 antibody testing.
Antibodies have been detected with seven completely different commercially accessible immunoassays. Frequencies of damaging RT-PCR and serology leads to people with COVID-19 have been decided and in comparison with these noticed in a validation cohort of Swiss sufferers (n=211).
Outcomes Amongst COVID-19 sufferers in Liechtenstein, false-negative RT-PCR at preliminary presentation was seen in 18% (12/66), whereas damaging serology in COVID-19 sufferers was 4% (3/85). The validation cohort confirmed related frequencies: 2/66 (3%) for damaging serology, and 16/155 (10%) for false damaging RT-PCR. COVID-19 sufferers with damaging follow-up serology tended to have an extended illness length (p=0.05) and extra scientific signs than different sufferers with COVID-19 (p<0.05).
The antibody titer from quantitative immunoassays was positively related to the variety of illness signs and illness length (p<0.001). Conclusions RT-PCR at preliminary presentation in sufferers with suspected COVID-19 can miss contaminated sufferers. Antibody titers of SARS-CoV-2 assays are linked to the variety of illness signs and the length of illness. One in 25 sufferers with RT-PCR-positive COVID-19 doesn’t develop antibodies detectable with incessantly employed and commercially accessible immunoassays.

![]() GPR119 antibody |
|||
70R-31399 | Fitzgerald | 100 ug | EUR 327 |
Description: Rabbit polyclonal GPR119 antibody |
![]() GPR119 Antibody |
|||
DF4892 | Affbiotech | 200ul | EUR 304 |
Description: GPR119 Antibody detects endogenous levels of total GPR119. |
![]() GPR119 Antibody |
|||
1-CSB-PA007283 | Cusabio |
|
|
Description: A polyclonal antibody against GPR119. Recognizes GPR119 from Human. This antibody is Unconjugated. Tested in the following application: WB, IF, ELISA;WB:1/500-1/2000.IF:1/200-1/1000.ELISA:1/10000 |
![]() Polyclonal Goat Anti-GPR119 Antibody |
|||
APR16300G | Leading Biology | 0.1 mg | EUR 484 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-GPR119 . This antibody is tested and proven to work in the following applications: |
![]() Gpr119/ Rat Gpr119 ELISA Kit |
|||
ELI-08203r | Lifescience Market | 96 Tests | EUR 886 |
![]() GPR119 Polyclonal Antibody |
|||
ES4819-100ul | ELK Biotech | 100ul | EUR 279 |
Description: A Rabbit Polyclonal antibody against GPR119 from Human. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
![]() GPR119 Polyclonal Antibody |
|||
ES4819-50ul | ELK Biotech | 50ul | EUR 207 |
Description: A Rabbit Polyclonal antibody against GPR119 from Human. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
![]() GPR119 Polyclonal Antibody |
|||
ABP53820-003ml | Abbkine | 0.03ml | EUR 158 |
Description: A polyclonal antibody for detection of GPR119 from Human. This GPR119 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human GPR119 at AA rangle: 160-240 |
![]() GPR119 Polyclonal Antibody |
|||
ABP53820-01ml | Abbkine | 0.1ml | EUR 289 |
Description: A polyclonal antibody for detection of GPR119 from Human. This GPR119 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human GPR119 at AA rangle: 160-240 |
![]() GPR119 Polyclonal Antibody |
|||
ABP53820-02ml | Abbkine | 0.2ml | EUR 414 |
Description: A polyclonal antibody for detection of GPR119 from Human. This GPR119 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human GPR119 at AA rangle: 160-240 |
![]() GPR119 Polyclonal Antibody |
|||
40973-100ul | SAB | 100ul | EUR 252 |
![]() GPR119 Polyclonal Antibody |
|||
40973-50ul | SAB | 50ul | EUR 187 |
![]() GPR119 siRNA |
|||
20-abx918416 | Abbexa |
|
|
![]() GPR119 siRNA |
|||
20-abx918417 | Abbexa |
|
|
![]() GPR119 siRNA |
|||
20-abx902267 | Abbexa |
|
|
![]() GPR119 Polyclonal Conjugated Antibody |
|||
C40973 | SAB | 100ul | EUR 397 |
![]() GPR119 Blocking Peptide |
|||
DF4892-BP | Affbiotech | 1mg | EUR 195 |
![]() GPR119 cloning plasmid |
|||
CSB-CL840575HU-10ug | Cusabio | 10ug | EUR 233 |
Description: A cloning plasmid for the GPR119 gene. |
![]() GPR119 Rabbit pAb |
|||
A18544-100ul | Abclonal | 100 ul | EUR 308 |
![]() GPR119 Rabbit pAb |
|||
A18544-200ul | Abclonal | 200 ul | EUR 459 |
![]() GPR119 Rabbit pAb |
|||
A18544-20ul | Abclonal | 20 ul | EUR 183 |
![]() GPR119 Rabbit pAb |
|||
A18544-50ul | Abclonal | 50 ul | EUR 223 |
![]() GPR119 Blocking Peptide |
|||
20-abx162463 | Abbexa |
|
|
![]() Polyclonal GPR119 Antibody (aa186-235) |
|||
APR16477G | Leading Biology | 0.05ml | EUR 484 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR119 (aa186-235). This antibody is tested and proven to work in the following applications: |
![]() Polyclonal GPR119 Antibody (Cytoplasmic Domain) |
|||
APR16478G | Leading Biology | 0.05mg | EUR 484 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR119 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications: |
![]() Polyclonal GPR119 Antibody (Cytoplasmic Domain) |
|||
APR16479G | Leading Biology | 0.05mg | EUR 484 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR119 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications: |
![]() Polyclonal Goat anti-GST α-form |
|||
GST-ANTI-1 | Detroit R&D | 50 uL | EUR 280 |
![]() Polyclonal Goat anti-GST μ-form |
|||
GST-ANTI-2 | Detroit R&D | 50 uL | EUR 280 |
![]() Polyclonal Goat anti-GST p-form |
|||
GST-ANTI-3 | Detroit R&D | 50 uL | EUR 280 |
![]() Mouse Gpr119 ELISA KIT |
|||
ELI-09750m | Lifescience Market | 96 Tests | EUR 865 |
![]() Human GPR119 ELISA KIT |
|||
ELI-48829h | Lifescience Market | 96 Tests | EUR 824 |
![]() GPR119 Recombinant Protein (Human) |
|||
RP039541 | ABM | 100 ug | Ask for price |
![]() GPR119 Recombinant Protein (Rat) |
|||
RP203282 | ABM | 100 ug | Ask for price |
![]() GPR119 Recombinant Protein (Mouse) |
|||
RP139418 | ABM | 100 ug | Ask for price |
![]() Mouse GPR119 shRNA Plasmid |
|||
20-abx982252 | Abbexa |
|
|
![]() Rat GPR119 shRNA Plasmid |
|||
20-abx989158 | Abbexa |
|
|
![]() Human GPR119 shRNA Plasmid |
|||
20-abx965265 | Abbexa |
|
|
![]() Gpr119 ORF Vector (Rat) (pORF) |
|||
ORF067762 | ABM | 1.0 ug DNA | EUR 506 |
![]() GPR119 ORF Vector (Human) (pORF) |
|||
ORF013181 | ABM | 1.0 ug DNA | EUR 354 |
![]() Gpr119 ORF Vector (Mouse) (pORF) |
|||
ORF046474 | ABM | 1.0 ug DNA | EUR 506 |
![]() G-Protein Coupled Receptor 119 (GPR119) Antibody |
|||
20-abx121407 | Abbexa |
|
|
![]() G-Protein Coupled Receptor 119 (GPR119) Antibody |
|||
abx432763-200ul | Abbexa | 200 ul | EUR 384 |
![]() G-Protein Coupled Receptor 119 (GPR119) Antibody |
|||
abx215630-100ug | Abbexa | 100 ug | EUR 439 |
![]() G Protein-Coupled Receptor 119 (GPR119) Antibody |
|||
20-abx324143 | Abbexa |
|
|
![]() Gpr119 sgRNA CRISPR Lentivector set (Rat) |
|||
K7204201 | ABM | 3 x 1.0 ug | EUR 339 |
![]() Gpr119 sgRNA CRISPR Lentivector set (Mouse) |
|||
K3605701 | ABM | 3 x 1.0 ug | EUR 339 |
![]() GPR119 sgRNA CRISPR Lentivector set (Human) |
|||
K0895801 | ABM | 3 x 1.0 ug | EUR 339 |
![]() GPR119 3'UTR Luciferase Stable Cell Line |
|||
TU009210 | ABM | 1.0 ml | EUR 2333 |
![]() Gpr119 3'UTR Luciferase Stable Cell Line |
|||
TU108968 | ABM | 1.0 ml | Ask for price |
![]() Gpr119 3'UTR Luciferase Stable Cell Line |
|||
TU205325 | ABM | 1.0 ml | Ask for price |
![]() Gpr119 3'UTR GFP Stable Cell Line |
|||
TU158968 | ABM | 1.0 ml | Ask for price |
![]() Gpr119 3'UTR GFP Stable Cell Line |
|||
TU255325 | ABM | 1.0 ml | Ask for price |
![]() GPR119 3'UTR GFP Stable Cell Line |
|||
TU059210 | ABM | 1.0 ml | EUR 2333 |
![]() GPR119 Protein Vector (Rat) (pPB-C-His) |
|||
PV271046 | ABM | 500 ng | EUR 603 |
![]() GPR119 Protein Vector (Rat) (pPB-N-His) |
|||
PV271047 | ABM | 500 ng | EUR 603 |
![]() GPR119 Protein Vector (Rat) (pPM-C-HA) |
|||
PV271048 | ABM | 500 ng | EUR 603 |
![]() GPR119 Protein Vector (Rat) (pPM-C-His) |
|||
PV271049 | ABM | 500 ng | EUR 603 |
![]() GPR119 Protein Vector (Mouse) (pPB-C-His) |
|||
PV185894 | ABM | 500 ng | EUR 603 |
![]() GPR119 Protein Vector (Mouse) (pPB-N-His) |
|||
PV185895 | ABM | 500 ng | EUR 603 |
![]() GPR119 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV185896 | ABM | 500 ng | EUR 603 |
![]() GPR119 Protein Vector (Mouse) (pPM-C-His) |
|||
PV185897 | ABM | 500 ng | EUR 603 |
![]() GPR119 Protein Vector (Human) (pPB-C-His) |
|||
PV052721 | ABM | 500 ng | EUR 481 |
![]() GPR119 Protein Vector (Human) (pPB-N-His) |
|||
PV052722 | ABM | 500 ng | EUR 481 |
![]() GPR119 Protein Vector (Human) (pPM-C-HA) |
|||
PV052723 | ABM | 500 ng | EUR 481 |
![]() GPR119 Protein Vector (Human) (pPM-C-His) |
|||
PV052724 | ABM | 500 ng | EUR 481 |
![]() Gpr119 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
K7204202 | ABM | 1.0 ug DNA | EUR 154 |
![]() Gpr119 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
K7204203 | ABM | 1.0 ug DNA | EUR 154 |
![]() Gpr119 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
K7204204 | ABM | 1.0 ug DNA | EUR 154 |
![]() Gpr119 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K3605702 | ABM | 1.0 ug DNA | EUR 154 |
![]() Gpr119 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K3605703 | ABM | 1.0 ug DNA | EUR 154 |
![]() Gpr119 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K3605704 | ABM | 1.0 ug DNA | EUR 154 |
![]() GPR119 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K0895802 | ABM | 1.0 ug DNA | EUR 154 |
![]() GPR119 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K0895803 | ABM | 1.0 ug DNA | EUR 154 |
![]() GPR119 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K0895804 | ABM | 1.0 ug DNA | EUR 154 |
![]() GPR119 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
LV629167 | ABM | 1.0 ug DNA | EUR 682 |
![]() GPR119 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
LV629171 | ABM | 1.0 ug DNA | EUR 682 |
![]() GPR119 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
LV629172 | ABM | 1.0 ug DNA | EUR 682 |
![]() Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
K7204205 | ABM | 3 x 1.0 ug | EUR 376 |
![]() Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K3605705 | ABM | 3 x 1.0 ug | EUR 376 |
![]() GPR119 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K0895805 | ABM | 3 x 1.0 ug | EUR 376 |
![]() GPR119 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
LV629168 | ABM | 1.0 ug DNA | EUR 682 |
![]() GPR119 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
LV629169 | ABM | 1.0 ug DNA | EUR 740 |
![]() GPR119 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
LV629170 | ABM | 1.0 ug DNA | EUR 740 |
![]() Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
K7204206 | ABM | 1.0 ug DNA | EUR 167 |
![]() Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
K7204207 | ABM | 1.0 ug DNA | EUR 167 |
![]() Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
K7204208 | ABM | 1.0 ug DNA | EUR 167 |
![]() Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
K3605706 | ABM | 1.0 ug DNA | EUR 167 |
![]() Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
K3605707 | ABM | 1.0 ug DNA | EUR 167 |
![]() Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
K3605708 | ABM | 1.0 ug DNA | EUR 167 |
![]() GPR119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
K0895806 | ABM | 1.0 ug DNA | EUR 167 |
![]() GPR119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
K0895807 | ABM | 1.0 ug DNA | EUR 167 |
![]() GPR119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
K0895808 | ABM | 1.0 ug DNA | EUR 167 |
![]() Anti-Anti-SEPT6 antibody antibody |
|||
STJ11100949 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
![]() Anti-Anti-SEPT9 Antibody antibody |
|||
STJ111369 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
When ought to clinicians repeat SARS-CoV-2 RT-PCR?: Repeat PCR testing concentrating on sufferers with pulmonary CT findings suggestive of COVID-19
Actual-time reverse transcription polymerase chain response (RT-PCR) testing for SARS-CoV-2 is usually repeated when clinicians suspect a false-negative consequence, however the situations beneath which repeated RT-PCR testing is warranted stay unclear.
We evaluated the apply of repeat RT-PCR testing for SARS-CoV-2 in 45 sufferers who retested after an preliminary damaging PCR take a look at. Of those, the analysis of coronavirus illness (COVID-19) was confirmed in 4 sufferers with typical chest computed tomography (CT) findings, and one affected person with out typical CT findings in whom the take a look at consequence was strongly suspected to be false constructive. We suggest repeat RT-PCR just for sufferers with typical CT findings of COVID-19.
A survey of gastrointestinal nematode species in purple deer (Cervus elaphus) farms in New Zealand utilizing PCR
Gastrointestinal nematodes are recognised as an animal well being concern for farmed purple deer. The intention of this research was to discover the vary of species infecting farmed deer herds and their farm-level prevalence in New Zealand. Faecal samples have been collected from 12-24-month-old deer (n = 6-26; imply 19) on 59 farms situated within the North (n = 25) and South (n = 34) Islands. Sub-samples of faeces have been pooled by farm and cultured to recuperate third stage larvae. Twenty 4 larvae have been randomly chosen and recognized to species utilizing a multiplex PCR (complete = 1217 larvae).
- At farm-level probably the most prevalent nematodes have been Oesophagostomum venulosum 83% (n = 49) and the deer-specific nematodes within the subfamily Ostertagiinae (=Ostertagia-type) together with, Spiculoptera asymmetrica 73% (n = 43), Ostertagia leptospicularis 47% (n = 28), Spiculoptera spiculoptera 47% (n = 28).
- The not too long ago recognized Trichostrongylus askivali was current on 32% (n = 19) of the farms and Oesophagostomum sikae on 17% (n = 10). Within the evaluation of the overall variety of larvae recognized, the proportion was in related order, 45% (n = 548) have been O. venulosum, 14% (n = 173) S. asymmetrica, 10% (n = 124) S. spiculoptera, 9% (n = 114) O. leptospicularis, T. askivali, 3% (n = 40) and solely 2% have been O. sikae (n = 20).
- This research is the primary to point out the farm-level prevalence of nematode species in deer in New Zealand and the primary to make use of PCR as a diagnostic device.
- It offers knowledge in step with cross-infection from sheep/cattle to deer, and offered tentative insights into the proportions of the principle GIN species throughout the deer inhabitants together with O. sikae and T. askivali which have solely not too long ago been recognized in New Zealand.
![]() GPR110 Antibody |
|||
ABD4891 | Lifescience Market | 100 ug | EUR 438 |
![]() GPR110 antibody |
|||
70R-31396 | Fitzgerald | 100 ug | EUR 327 |
Description: Rabbit polyclonal GPR110 antibody |
![]() GPR110 Antibody |
|||
DF2796 | Affbiotech | 200ul | EUR 304 |
Description: GPR110 antibody detects endogenous levels of total GPR110. |
![]() GPR110 Antibody |
|||
DF4891 | Affbiotech | 200ul | EUR 304 |
Description: GPR110 Antibody detects endogenous levels of total GPR110. |
![]() GPR110 Antibody |
|||
1-CSB-PA002753 | Cusabio |
|
|
Description: A polyclonal antibody against GPR110. Recognizes GPR110 from Human. This antibody is Unconjugated. Tested in the following application: WB, IF, ELISA;WB:1/500-1/2000.IF:1/200-1/1000.ELISA:1/40000 |
![]() GPR110 Antibody |
|||
44961-100ul | SAB | 100ul | EUR 252 |
![]() GPR110 Antibody |
|||
44961-50ul | SAB | 50ul | EUR 187 |
![]() Rabbit Polyclonal antibody Anti-CRBN |
|||
Anti-CRBN | ImmunoStep | 50 µg | EUR 349 |
![]() GPR110 Polyclonal Antibody |
|||
ABP51449-003ml | Abbkine | 0.03ml | EUR 158 |
Description: A polyclonal antibody for detection of GPR110 from Human. This GPR110 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human GPR110 at AA range: 810-890 |
![]() GPR110 Polyclonal Antibody |
|||
ABP51449-01ml | Abbkine | 0.1ml | EUR 289 |
Description: A polyclonal antibody for detection of GPR110 from Human. This GPR110 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human GPR110 at AA range: 810-890 |
![]() GPR110 Polyclonal Antibody |
|||
ABP51449-02ml | Abbkine | 0.2ml | EUR 414 |
Description: A polyclonal antibody for detection of GPR110 from Human. This GPR110 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human GPR110 at AA range: 810-890 |
![]() Polyclonal GPR110 Antibody |
|||
APR12205G | Leading Biology | 0.1ml | EUR 484 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR110 . This antibody is tested and proven to work in the following applications: |
![]() GPR110 Polyclonal Antibody |
|||
ES2448-100ul | ELK Biotech | 100ul | EUR 279 |
Description: A Rabbit Polyclonal antibody against GPR110 from Human. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
![]() GPR110 Polyclonal Antibody |
|||
ES2448-50ul | ELK Biotech | 50ul | EUR 207 |
Description: A Rabbit Polyclonal antibody against GPR110 from Human. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
![]() GPR110 Conjugated Antibody |
|||
C44961 | SAB | 100ul | EUR 397 |
![]() GPR110 siRNA |
|||
20-abx918404 | Abbexa |
|
|
![]() GPR110 siRNA |
|||
20-abx918405 | Abbexa |
|
|
![]() GPR110 Blocking Peptide |
|||
DF2796-BP | Affbiotech | 1mg | EUR 195 |
![]() GPR110 Blocking Peptide |
|||
DF4891-BP | Affbiotech | 1mg | EUR 195 |
![]() GPR110 Blocking Peptide |
|||
20-abx064092 | Abbexa |
|
|
![]() Polyclonal Goat anti-GST α-form |
|||
GST-ANTI-1 | Detroit R&D | 50 uL | EUR 280 |
![]() Polyclonal Goat anti-GST μ-form |
|||
GST-ANTI-2 | Detroit R&D | 50 uL | EUR 280 |
![]() Polyclonal Goat anti-GST p-form |
|||
GST-ANTI-3 | Detroit R&D | 50 uL | EUR 280 |
![]() Mouse GPR110 shRNA Plasmid |
|||
20-abx978802 | Abbexa |
|
|
![]() Human GPR110 shRNA Plasmid |
|||
20-abx966836 | Abbexa |
|
|
![]() GPR110 ORF Vector (Human) (pORF) |
|||
ORF020338 | ABM | 1.0 ug DNA | EUR 405 |
![]() Gpr110 ORF Vector (Mouse) (pORF) |
|||
ORF046467 | ABM | 1.0 ug DNA | EUR 506 |
![]() G Protein-Coupled Receptor 110 (GPR110) Antibody |
|||
20-abx147426 | Abbexa |
|
|
![]() G Protein-Coupled Receptor 110 (GPR110) Antibody |
|||
20-abx007923 | Abbexa |
|
|
![]() G Protein-Coupled Receptor 110 (GPR110) Antibody |
|||
20-abx015251 | Abbexa |
|
|
![]() Gpr110 sgRNA CRISPR Lentivector set (Mouse) |
|||
K3842201 | ABM | 3 x 1.0 ug | EUR 339 |
![]() GPR110 sgRNA CRISPR Lentivector set (Human) |
|||
K0894901 | ABM | 3 x 1.0 ug | EUR 339 |
![]() GPR110 3'UTR Luciferase Stable Cell Line |
|||
TU009201 | ABM | 1.0 ml | EUR 1521 |
![]() Gpr110 3'UTR Luciferase Stable Cell Line |
|||
TU108961 | ABM | 1.0 ml | Ask for price |
![]() Gpr110 3'UTR GFP Stable Cell Line |
|||
TU158961 | ABM | 1.0 ml | Ask for price |
![]() GPR110 3'UTR GFP Stable Cell Line |
|||
TU059201 | ABM | 1.0 ml | EUR 1521 |
![]() GPR110 Protein Vector (Mouse) (pPB-C-His) |
|||
PV185866 | ABM | 500 ng | EUR 1065 |
![]() GPR110 Protein Vector (Mouse) (pPB-N-His) |
|||
PV185867 | ABM | 500 ng | EUR 1065 |
![]() GPR110 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV185868 | ABM | 500 ng | EUR 1065 |
![]() GPR110 Protein Vector (Mouse) (pPM-C-His) |
|||
PV185869 | ABM | 500 ng | EUR 1065 |
![]() GPR110 Protein Vector (Human) (pPB-C-His) |
|||
PV081349 | ABM | 500 ng | EUR 552 |
![]() GPR110 Protein Vector (Human) (pPB-N-His) |
|||
PV081350 | ABM | 500 ng | EUR 552 |
![]() GPR110 Protein Vector (Human) (pPM-C-HA) |
|||
PV081351 | ABM | 500 ng | EUR 552 |
![]() GPR110 Protein Vector (Human) (pPM-C-His) |
|||
PV081352 | ABM | 500 ng | EUR 552 |
![]() Gpr110 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K3842202 | ABM | 1.0 ug DNA | EUR 154 |
![]() Gpr110 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K3842203 | ABM | 1.0 ug DNA | EUR 154 |
![]() Gpr110 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K3842204 | ABM | 1.0 ug DNA | EUR 154 |
![]() GPR110 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K0894902 | ABM | 1.0 ug DNA | EUR 154 |
![]() GPR110 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K0894903 | ABM | 1.0 ug DNA | EUR 154 |
![]() GPR110 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K0894904 | ABM | 1.0 ug DNA | EUR 154 |
![]() Mouse G- protein coupled receptor 110, Gpr110 ELISA KIT |
|||
ELI-09748m | Lifescience Market | 96 Tests | EUR 865 |
![]() Human Probable G- protein coupled receptor 110, GPR110 ELISA KIT |
|||
ELI-08749h | Lifescience Market | 96 Tests | EUR 824 |
![]() Gpr110 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K3842205 | ABM | 3 x 1.0 ug | EUR 376 |
![]() GPR110 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K0894905 | ABM | 3 x 1.0 ug | EUR 376 |
![]() Gpr110 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
K3842206 | ABM | 1.0 ug DNA | EUR 167 |
![]() Gpr110 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
K3842207 | ABM | 1.0 ug DNA | EUR 167 |
![]() Gpr110 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
K3842208 | ABM | 1.0 ug DNA | EUR 167 |
![]() GPR110 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
K0894906 | ABM | 1.0 ug DNA | EUR 167 |
![]() GPR110 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
K0894907 | ABM | 1.0 ug DNA | EUR 167 |
![]() GPR110 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
K0894908 | ABM | 1.0 ug DNA | EUR 167 |
![]() Anti-Anti-SEPT2 Antibody antibody |
|||
STJ25475 | St John's Laboratory | 100 µl | EUR 277 |
![]() Anti-Anti-SEPT5 Antibody antibody |
|||
STJ25477 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
![]() Anti-Anti-SEPT8 Antibody antibody |
|||
STJ25479 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
![]() Anti-Anti-SEPT2 Antibody antibody |
|||
STJ28365 | St John's Laboratory | 100 µl | EUR 277 |
![]() Anti-Anti-SEPT7 Antibody antibody |
|||
STJ28963 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
![]() Anti-Anti-SEPT8 Antibody antibody |
|||
STJ117206 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
![]() Anti-Anti-SEPT12 Antibody antibody |
|||
STJ117759 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
![]() Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118549 | St John's Laboratory | 100 µl | EUR 277 |
![]() Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118550 | St John's Laboratory | 100 µl | EUR 277 |
![]() Anti-Anti-MARCH7 Antibody antibody |
|||
STJ118752 | St John's Laboratory | 100 µl | EUR 277 |
![]() Anti-Anti-SEPT3 Antibody antibody |
|||
STJ118990 | St John's Laboratory | 100 µl | EUR 277 |
![]() Anti-Anti-SEPT1 antibody antibody |
|||
STJ119580 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
![]() Anti-Anti-SEPT7 Antibody antibody |
|||
STJ116214 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
![]() Anti-Anti-SEPT6 antibody antibody |
|||
STJ11100949 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
![]() Anti-Anti-SEPT9 Antibody antibody |
|||
STJ111369 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
![]() Anti-Anti-SEPT11 Antibody antibody |
|||
STJ111530 | St John's Laboratory | 100 µl | EUR 277 |
![]() Anti-Anti-SEPT4 Antibody antibody |
|||
STJ112276 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
![]() Anti-Anti-MARCH9 Antibody antibody |
|||
STJ112609 | St John's Laboratory | 100 µl | EUR 277 |
![]() Anti-Anti-SEPT11 Antibody antibody |
|||
STJ113941 | St John's Laboratory | 100 µl | EUR 277 |
![]() Anti-Anti-SEPT11 Antibody antibody |
|||
STJ114081 | St John's Laboratory | 100 µl | EUR 277 |
![]() Anti-Anti-SEPT5 Antibody antibody |
|||
STJ114819 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
![]() Anti-Anti-MARCH8 Antibody antibody |
|||
STJ114828 | St John's Laboratory | 100 µl | EUR 277 |
![]() Anti-Anti-DDB1 Antibody |
|||
A00333 | BosterBio | 100uL | EUR 455 |
Description: Rabbit Polyclonal DDB1 Antibody. Validated in IP and tested in Human, Mouse. |
![]() Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
AEA465Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 5647.8 |
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
![]() Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
AEA465Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 552.76 |
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
![]() Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
AEA465Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 746.8 |
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
![]() Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
AEA465Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 3060.6 |
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
![]() Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
4-AEA465Hu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species. |
![]() ELISA kit for Human Anti-AsAb (Anti-Anti-Sperm Antibody Antibody) |
|||
ELK8071 | ELK Biotech | 1 plate of 96 wells | EUR 432 |
Description: A competitive Inhibition ELISA kit for detection of Anti-Anti-Sperm Antibody Antibody from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
![]() Anti- ZNF660 antibody |
|||
ABD2410 | Lifescience Market | 100 ug | EUR 438 |
![]() Anti-STAT5B Antibody |
|||
A1753-100 | Biovision | EUR 479 |
![]() Anti-CREB1 Antibody |
|||
A1754-100 | Biovision | EUR 479 |
![]() Anti-COX7B Antibody |
|||
A1756-100 | Biovision | EUR 479 |
![]() Anti-COX6B1 Antibody |
|||
A1757-100 | Biovision | EUR 479 |